Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002007.SZ Stock Summary
Top 10 Correlated ETFs
002007.SZ
In the News
002007.SZ Financial details
Company Rating
Buy
Market Cap
39.66B
Income
1.02B
Revenue
3.75B
Book val./share
5.9
Cash/share
1.95
Dividend
0.3
Dividend %
1.35%
Employees
3.24K
Optionable
No
Shortable
Yes
Earnings
24 Aug 2023
P/E
33.91
Forward P/E
-
PEG
-15.27
P/S
8.51
P/B
3.77
P/C
11.38
P/FCF
53.24
Quick Ratio
2.74
Current Ratio
3.72
Debt / Equity
0.1
LT Debt / Equity
0.03
-
-
EPS (TTM)
0.55
EPS next Y
-
EPS next Q
-
EPS this Y
-16.9%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.3%
Revenue last 5Y
7.02%
Revenue Q/Q
-19.99%
EPS Q/Q
-49.53%
-
-
-
-
SMA20
4.76%
SMA50
-
SMA100
-4.35%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
12%
ROC
0.12%
Gross Margin
66%
Oper. Margin
34%
Profit Margin
25%
Payout
33%
Shs Outstand
1.82B
Shs Float
960.64M
-
-
-
-
Target Price
-
52W Range
17.01-25.09
52W High
-11.2%
52W Low
+30.59%
RSI
62
Rel Volume
0.89
Avg Volume
6.8M
Volume
6.05M
Perf Week
0.45%
Perf Month
-0.63%
Perf Quarter
-5.25%
Perf Half Y
0.23%
-
-
-
-
Beta
0.306364
-
-
Volatility
0.2%, 0.41%
Prev Close
-0.05%
Price
22.2
Change
0.27%
002007.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 1.77 | 2.04 | 2.76 | 2.44 | 2.47 | |
Net income per share | 0.63 | 0.71 | 0.89 | 0.71 | 0.59 | |
Operating cash flow per share | 0.71 | 0.75 | 0.73 | 0.79 | 0.52 | |
Free cash flow per share | 0.61 | 0.6 | 0.39 | 0.34 | 0.31 | |
Cash per share | 0.23 | 1.86 | 2.21 | 1.84 | 1.9 | |
Book value per share | 3.05 | 3.6 | 4.14 | 4.58 | 5.7 | |
Tangible book value per share | 3.06 | 3.67 | 4.34 | 4.85 | 6.51 | |
Share holders equity per share | 3.05 | 3.6 | 4.14 | 4.58 | 5.7 | |
Interest debt per share | 0 | 0 | 0.22 | 0.56 | 0.62 | |
Market cap | 44.57B | 49.12B | 76.79B | 53.06B | 41.3B | |
Enterprise value | 44.15B | 48.06B | 76.15B | 53.37B | 41.31B | |
P/E ratio | 39.12 | 38.27 | 47.61 | 40.85 | 38.38 | |
Price to sales ratio | 13.86 | 13.28 | 15.29 | 11.96 | 9.14 | |
POCF ratio | 34.48 | 36.05 | 57.94 | 37.04 | 43.14 | |
PFCF ratio | 40.18 | 45.07 | 109.1 | 85.43 | 73.31 | |
P/B Ratio | 8.06 | 7.51 | 10.2 | 6.36 | 3.97 | |
PTB ratio | 8.06 | 7.51 | 10.2 | 6.36 | 3.97 | |
EV to sales | 13.72 | 12.99 | 15.16 | 12.03 | 9.15 | |
Enterprise value over EBITDA | 28.38 | 26.56 | 31.7 | 26.27 | 21.78 | |
EV to operating cash flow | 34.15 | 35.27 | 57.46 | 37.26 | 43.16 | |
EV to free cash flow | 39.79 | 44.1 | 108.2 | 85.92 | 73.33 | |
Earnings yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | |
Free cash flow yield | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0 | 0.05 | 0.12 | 0.11 | |
Debt to assets | 0 | 0 | 0.04 | 0.09 | 0.08 | |
Net debt to EBITDA | -0.28 | -0.59 | -0.27 | 0.15 | 0.01 | |
Current ratio | 6.64 | 8.19 | 3.92 | 3.09 | 3.76 | |
Interest coverage | 246.15 | 228.22 | 432.74 | 78.09 | 47.06 | |
Income quality | 1.07 | 0.99 | 0.72 | 0.99 | 0.77 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.24 | 0.3 | 0.35 | 0.43 | 0.37 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.05 | 0.04 | 0.04 | 0.06 | 0.07 | |
Intangibles to total assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -0.14 | -0.2 | -0.47 | -0.57 | -0.41 | |
Capex to revenue | -0.06 | -0.07 | -0.12 | -0.18 | -0.09 | |
Capex to depreciation | -1.32 | -1.7 | -3.42 | -4.13 | -1.44 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.56 | 7.57 | 9.09 | 8.57 | 8.69 | |
ROIC | 0.22 | 0.21 | 0.23 | 0.16 | 0.11 | |
Return on tangible assets | 0.18 | 0.17 | 0.16 | 0.11 | 0.07 | |
Graham Net | 0.63 | 2.26 | 2.42 | 1.74 | 1.97 | |
Working capital | 4.06B | 4.99B | 5.6B | 4.64B | 5.93B | |
Tangible asset value | 5.55B | 6.67B | 7.88B | 8.84B | 11.88B | |
Net current asset value | 4.06B | 4.99B | 5.57B | 4.38B | 5.55B | |
Invested capital | 0 | 0 | 0.05 | 0.12 | 0.11 | |
Average receivables | 1.04B | 1.13B | 1.73B | 2.22B | 2.36B | |
Average payables | 66.82M | 65.05M | 113.56M | 201.77M | 208.26M | |
Average inventory | 1.21B | 1.18B | 1.17B | 1.27B | 1.4B | |
Days sales outstanding | 126.67 | 113.51 | 167.87 | 175.88 | 208.15 | |
Days payables outstanding | 21.22 | 18.19 | 43.26 | 63.43 | 41.79 | |
Days of inventory on hand | 389.94 | 326.4 | 312.67 | 357.6 | 344.48 | |
Receivables turnover | 2.88 | 3.22 | 2.17 | 2.08 | 1.75 | |
Payables turnover | 17.2 | 20.07 | 8.44 | 5.75 | 8.73 | |
Inventory turnover | 0.94 | 1.12 | 1.17 | 1.02 | 1.06 | |
ROE | 0.21 | 0.2 | 0.21 | 0.16 | 0.1 | |
Capex per share | -0.1 | -0.15 | -0.34 | -0.45 | -0.22 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.35 | 0.94 | 0.69 | 0.5 | 0.48 | |
Net income per share | 0.13 | 0.19 | 0.17 | 0.1 | 0.19 | |
Operating cash flow per share | 0.03 | 0.19 | 0.17 | 0.1 | 0.19 | |
Free cash flow per share | -0.05 | 0.19 | 0.15 | -0.01 | 0.09 | |
Cash per share | 2.67 | 2.68 | 1.98 | 1.9 | 1.95 | |
Book value per share | 5.44 | 5.44 | 5.61 | 5.7 | 5.9 | |
Tangible book value per share | 6.23 | 6.2 | 6.42 | 6.52 | 6.72 | |
Share holders equity per share | 5.44 | 5.44 | 5.61 | 5.7 | 5.9 | |
Interest debt per share | 0.55 | 0.72 | 0.44 | 0.61 | 0.61 | |
Market cap | 36.99B | 41.53B | 33.08B | 41.25B | 39.82B | |
Enterprise value | 35.91B | 40.84B | 32.73B | 41.26B | 40.2B | |
P/E ratio | 39.54 | 29.74 | 26.04 | 58.7 | 28.31 | |
Price to sales ratio | 57.74 | 24.3 | 26.4 | 45.1 | 45.21 | |
POCF ratio | 632.74 | 118.95 | 104.14 | 234.81 | 113.23 | |
PFCF ratio | -435.28 | 121.42 | 121.96 | -1.93K | 235.77 | |
P/B Ratio | 3.73 | 4.19 | 3.24 | 3.97 | 3.7 | |
PTB ratio | 3.73 | 4.19 | 3.24 | 3.97 | 3.7 | |
EV to sales | 56.06 | 23.9 | 26.12 | 45.11 | 45.65 | |
Enterprise value over EBITDA | 132.05 | 76.52 | 73.09 | 111.42 | 105.34 | |
EV to operating cash flow | 614.29 | 116.98 | 103.05 | 234.88 | 114.32 | |
EV to free cash flow | -422.59 | 119.41 | 120.69 | -1.94K | 238.04 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Free cash flow yield | 0 | 0.01 | 0.01 | 0 | 0 | |
Debt to equity | 0.1 | 0.13 | 0.08 | 0.11 | 0.1 | |
Debt to assets | 0.07 | 0.09 | 0.05 | 0.08 | 0.07 | |
Net debt to EBITDA | -3.97 | -1.29 | -0.77 | 0.03 | 1.01 | |
Current ratio | 3.99 | 3.38 | 3.55 | 3.76 | 3.72 | |
Interest coverage | 34.64 | 66.07 | 51.95 | 31.19 | 120.94 | |
Income quality | 0.25 | 1 | 1 | 1 | 1 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.04 | 1.06 | 0.05 | 0.03 | 0.01 | |
Sales general and administrative to revenue | 0.08 | -0.02 | 0.15 | -0.18 | 0.07 | |
Research and developement to revenue | 0.1 | 0.05 | 0.06 | 0.1 | 0.09 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex to operating cash flow | -2.45 | -0.02 | -0.15 | -1.12 | -0.52 | |
Capex to revenue | -0.22 | 0 | -0.04 | -0.22 | -0.21 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.97 | 4.84 | 4.69 | 3.52 | 5.06 | |
ROIC | 0.02 | 0.04 | 0.04 | 0.02 | 0.03 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
Graham Net | 2.64 | 2.62 | 2.25 | 1.97 | 1.94 | |
Working capital | 6.42B | 6.51B | 5.9B | 5.93B | 5.69B | |
Tangible asset value | 11.35B | 11.3B | 11.68B | 11.88B | 12.27B | |
Net current asset value | 6.15B | 6.26B | 5.64B | 5.55B | 5.31B | |
Invested capital | 0.1 | 0.13 | 0.08 | 0.11 | 0.1 | |
Average receivables | 2.09B | 2.41B | 2.9B | 2.8B | 2.38B | |
Average payables | 288.81M | 284.62M | 315.6M | 287.02M | 194.09M | |
Average inventory | 1.51B | 1.63B | 1.58B | 1.51B | 1.54B | |
Days sales outstanding | 286.8 | 145.94 | 217.09 | 253.47 | 223.31 | |
Days payables outstanding | 119.85 | 41.51 | 83.5 | 45.63 | 58.84 | |
Days of inventory on hand | 594.46 | 282.07 | 329.99 | 376.2 | 453.6 | |
Receivables turnover | 0.31 | 0.62 | 0.41 | 0.36 | 0.4 | |
Payables turnover | 0.75 | 2.17 | 1.08 | 1.97 | 1.53 | |
Inventory turnover | 0.15 | 0.32 | 0.27 | 0.24 | 0.2 | |
ROE | 0.02 | 0.04 | 0.03 | 0.02 | 0.03 | |
Capex per share | -0.08 | 0 | -0.03 | -0.11 | -0.1 |
002007.SZ Frequently Asked Questions
What is Hualan Biological Engineering Inc. stock symbol ?
Hualan Biological Engineering Inc. is a CN stock and trading under the symbol 002007.SZ
What is Hualan Biological Engineering Inc. stock quote today ?
Hualan Biological Engineering Inc. stock price is $22.2 today.
Is Hualan Biological Engineering Inc. stock public?
Yes, Hualan Biological Engineering Inc. is a publicly traded company.